# Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII

> **NCT02093845** · NA · UNKNOWN · sponsor: **Aarhus University Hospital Skejby** · enrollment: 2800 (actual)

## Conditions studied

- Coronary Artery Disease
- Ischemic Heart Disease

## Interventions

- **DEVICE:** Biomatrix NeoFlex coronary stent
- **DEVICE:** SYNERGY stent

## Key facts

- **NCT ID:** NCT02093845
- **Lead sponsor:** Aarhus University Hospital Skejby
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02-10
- **Primary completion:** 2015-08-24
- **Final completion:** 2020-12-31
- **Target enrollment:** 2800 (ACTUAL)
- **Last updated:** 2017-04-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02093845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02093845, "Everolimus-eluting SYNERGY Stent Versus Biolimus-eluting Biomatrix NeoFlex Stent - SORT-OUT VIII". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02093845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*